 | • レポートコード：GIR-107A12435 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、長寿・老化防止療法のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。長寿・老化防止療法の種類別市場規模（溶血性薬物療法、遺伝子治療、免疫療法、その他幹細胞治療）、用途別市場規模（病院、医療機関、医薬品・機器販売）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・長寿・老化防止療法の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：CohBar、TA Sciences、Unity Biotechnology、AgeX Therapeutics，Inc、PowerVision Inc. ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：溶血性薬物療法、遺伝子治療、免疫療法、その他幹細胞治療 ・用途別分析2016年-2026年：病院、医療機関、医薬品・機器販売 ・長寿・老化防止療法の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・長寿・老化防止療法のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・長寿・老化防止療法のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・長寿・老化防止療法の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・長寿・老化防止療法の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Longevity and Anti-senescence Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Longevity and Anti-senescence Therapy size is estimated to be USD 441.6 million in 2026 from USD 327.6 million in 2020, with a change XX% between 2020 and 2021. The global Longevity and Anti-senescence Therapy market size is expected to grow at a CAGR of 7.8% for the next five years.
Market segmentation
Longevity and Anti-senescence Therapy market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Hemolytic Drug Therapy
Gene Therapy
Immunotherapy
Other Stem Cell Therapies
Market segment by Application, can be divided into
Hospital
Medical Service Institution
Drug and Device Sales
Market segment by players, this report covers
CohBar
TA Sciences
Unity Biotechnology
AgeX Therapeutics，Inc
PowerVision Inc.
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
1 Market Overview
1.1 Product Overview and Scope of Longevity and Anti-senescence Therapy
1.2 Classification of Longevity and Anti-senescence Therapy by Type
1.2.1 Overview: Global Longevity and Anti-senescence Therapy Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Longevity and Anti-senescence Therapy Revenue Market Share by Type in 2020
1.2.3 Hemolytic Drug Therapy
1.2.4 Gene Therapy
1.2.5 Immunotherapy
1.2.6 Other Stem Cell Therapies
1.3 Global Longevity and Anti-senescence Therapy Market by Application
1.3.1 Overview: Global Longevity and Anti-senescence Therapy Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Medical Service Institution
1.3.4 Drug and Device Sales
1.4 Global Longevity and Anti-senescence Therapy Market Size & Forecast
1.5 Global Longevity and Anti-senescence Therapy Market Size and Forecast by Region
1.5.1 Global Longevity and Anti-senescence Therapy Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Longevity and Anti-senescence Therapy Market Size by Region, (2016-2021)
1.5.3 North America Longevity and Anti-senescence Therapy Market Size and Prospect (2016-2026)
1.5.4 Europe Longevity and Anti-senescence Therapy Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Longevity and Anti-senescence Therapy Market Size and Prospect (2016-2026)
1.5.6 South America Longevity and Anti-senescence Therapy Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Longevity and Anti-senescence Therapy Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Longevity and Anti-senescence Therapy Market Drivers
1.6.2 Longevity and Anti-senescence Therapy Market Restraints
1.6.3 Longevity and Anti-senescence Therapy Trends Analysis
2 Company Profiles
2.1 CohBar
2.1.1 CohBar Details
2.1.2 CohBar Major Business
2.1.3 CohBar Longevity and Anti-senescence Therapy Product and Solutions
2.1.4 CohBar Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 CohBar Recent Developments and Future Plans
2.2 TA Sciences
2.2.1 TA Sciences Details
2.2.2 TA Sciences Major Business
2.2.3 TA Sciences Longevity and Anti-senescence Therapy Product and Solutions
2.2.4 TA Sciences Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 TA Sciences Recent Developments and Future Plans
2.3 Unity Biotechnology
2.3.1 Unity Biotechnology Details
2.3.2 Unity Biotechnology Major Business
2.3.3 Unity Biotechnology Longevity and Anti-senescence Therapy Product and Solutions
2.3.4 Unity Biotechnology Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Unity Biotechnology Recent Developments and Future Plans
2.4 AgeX Therapeutics，Inc
2.4.1 AgeX Therapeutics，Inc Details
2.4.2 AgeX Therapeutics，Inc Major Business
2.4.3 AgeX Therapeutics，Inc Longevity and Anti-senescence Therapy Product and Solutions
2.4.4 AgeX Therapeutics，Inc Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 AgeX Therapeutics，Inc Recent Developments and Future Plans
2.5 PowerVision Inc.
2.5.1 PowerVision Inc. Details
2.5.2 PowerVision Inc. Major Business
2.5.3 PowerVision Inc. Longevity and Anti-senescence Therapy Product and Solutions
2.5.4 PowerVision Inc. Longevity and Anti-senescence Therapy Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 PowerVision Inc. Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Longevity and Anti-senescence Therapy Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Longevity and Anti-senescence Therapy Players Market Share
3.2.2 Top 10 Longevity and Anti-senescence Therapy Players Market Share
3.2.3 Market Competition Trend
3.3 Longevity and Anti-senescence Therapy Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Longevity and Anti-senescence Therapy Revenue and Market Share by Type (2016-2021)
4.2 Global Longevity and Anti-senescence Therapy Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Longevity and Anti-senescence Therapy Revenue Market Share by Application (2016-2021)
5.2 Longevity and Anti-senescence Therapy Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Longevity and Anti-senescence Therapy Revenue by Type (2016-2026)
6.2 North America Longevity and Anti-senescence Therapy Revenue by Application (2016-2026)
6.3 North America Longevity and Anti-senescence Therapy Market Size by Country
6.3.1 North America Longevity and Anti-senescence Therapy Revenue by Country (2016-2026)
6.3.2 United States Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
6.3.3 Canada Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
6.3.4 Mexico Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Longevity and Anti-senescence Therapy Revenue by Type (2016-2026)
7.2 Europe Longevity and Anti-senescence Therapy Revenue by Application (2016-2026)
7.3 Europe Longevity and Anti-senescence Therapy Market Size by Country
7.3.1 Europe Longevity and Anti-senescence Therapy Revenue by Country (2016-2026)
7.3.2 Germany Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
7.3.3 France Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
7.3.5 Russia Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
7.3.6 Italy Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Longevity and Anti-senescence Therapy Revenue by Type (2016-2026)
8.2 Asia-Pacific Longevity and Anti-senescence Therapy Revenue by Application (2016-2026)
8.3 Asia-Pacific Longevity and Anti-senescence Therapy Market Size by Region
8.3.1 Asia-Pacific Longevity and Anti-senescence Therapy Revenue by Region (2016-2026)
8.3.2 China Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
8.3.3 Japan Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
8.3.4 South Korea Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
8.3.5 India Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
8.3.7 Australia Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Longevity and Anti-senescence Therapy Revenue by Type (2016-2026)
9.2 South America Longevity and Anti-senescence Therapy Revenue by Application (2016-2026)
9.3 South America Longevity and Anti-senescence Therapy Market Size by Country
9.3.1 South America Longevity and Anti-senescence Therapy Revenue by Country (2016-2026)
9.3.2 Brazil Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
9.3.3 Argentina Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Longevity and Anti-senescence Therapy Revenue by Type (2016-2026)
10.2 Middle East & Africa Longevity and Anti-senescence Therapy Revenue by Application (2016-2026)
10.3 Middle East & Africa Longevity and Anti-senescence Therapy Market Size by Country
10.3.1 Middle East & Africa Longevity and Anti-senescence Therapy Revenue by Country (2016-2026)
10.3.2 Turkey Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
10.3.4 UAE Longevity and Anti-senescence Therapy Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
Table 1. Global Longevity and Anti-senescence Therapy Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Longevity and Anti-senescence Therapy Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Longevity and Anti-senescence Therapy Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Longevity and Anti-senescence Therapy Revenue (USD Million) by Region (2016-2021)
Table 5. Global Longevity and Anti-senescence Therapy Revenue Market Share by Region (2021-2026)
Table 6. CohBar Corporate Information, Head Office, and Major Competitors
Table 7. CohBar Major Business
Table 8. CohBar Longevity and Anti-senescence Therapy Product and Solutions
Table 9. CohBar Longevity and Anti-senescence Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. TA Sciences Corporate Information, Head Office, and Major Competitors
Table 11. TA Sciences Major Business
Table 12. TA Sciences Longevity and Anti-senescence Therapy Product and Solutions
Table 13. TA Sciences Longevity and Anti-senescence Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Unity Biotechnology Corporate Information, Head Office, and Major Competitors
Table 15. Unity Biotechnology Major Business
Table 16. Unity Biotechnology Longevity and Anti-senescence Therapy Product and Solutions
Table 17. Unity Biotechnology Longevity and Anti-senescence Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. AgeX Therapeutics，Inc Corporate Information, Head Office, and Major Competitors
Table 19. AgeX Therapeutics，Inc Major Business
Table 20. AgeX Therapeutics，Inc Longevity and Anti-senescence Therapy Product and Solutions
Table 21. AgeX Therapeutics，Inc Longevity and Anti-senescence Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. PowerVision Inc. Corporate Information, Head Office, and Major Competitors
Table 23. PowerVision Inc. Major Business
Table 24. PowerVision Inc. Longevity and Anti-senescence Therapy Product and Solutions
Table 25. PowerVision Inc. Longevity and Anti-senescence Therapy Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Global Longevity and Anti-senescence Therapy Revenue (USD Million) by Players (2019-2021)
Table 27. Global Longevity and Anti-senescence Therapy Revenue Share by Players (2019-2021)
Table 28. Breakdown of Longevity and Anti-senescence Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 29. Longevity and Anti-senescence Therapy Players Head Office, Products and Services Provided
Table 30. Longevity and Anti-senescence Therapy Mergers & Acquisitions in the Past Five Years
Table 31. Longevity and Anti-senescence Therapy New Entrants and Expansion Plans
Table 32. Global Longevity and Anti-senescence Therapy Revenue (USD Million) by Type (2016-2021)
Table 33. Global Longevity and Anti-senescence Therapy Revenue Share by Type (2016-2021)
Table 34. Global Longevity and Anti-senescence Therapy Revenue Forecast by Type (2021-2026)
Table 35. Global Longevity and Anti-senescence Therapy Revenue by Application (2016-2021)
Table 36. Global Longevity and Anti-senescence Therapy Revenue Forecast by Application (2021-2026)
Table 37. North America Longevity and Anti-senescence Therapy Revenue by Type (2016-2021) & (USD Million)
Table 38. North America Longevity and Anti-senescence Therapy Revenue by Type (2021-2026) & (USD Million)
Table 39. North America Longevity and Anti-senescence Therapy Revenue by Application (2016-2021) & (USD Million)
Table 40. North America Longevity and Anti-senescence Therapy Revenue by Application (2021-2026) & (USD Million)
Table 41. North America Longevity and Anti-senescence Therapy Revenue by Country (2016-2021) & (USD Million)
Table 42. North America Longevity and Anti-senescence Therapy Revenue by Country (2021-2026) & (USD Million)
Table 43. Europe Longevity and Anti-senescence Therapy Revenue by Type (2016-2021) & (USD Million)
Table 44. Europe Longevity and Anti-senescence Therapy Revenue by Type (2021-2026) & (USD Million)
Table 45. Europe Longevity and Anti-senescence Therapy Revenue by Application (2016-2021) & (USD Million)
Table 46. Europe Longevity and Anti-senescence Therapy Revenue by Application (2021-2026) & (USD Million)
Table 47. Europe Longevity and Anti-senescence Therapy Revenue by Country (2016-2021) & (USD Million)
Table 48. Europe Longevity and Anti-senescence Therapy Revenue by Country (2021-2026) & (USD Million)
Table 49. Asia-Pacific Longevity and Anti-senescence Therapy Revenue by Type (2016-2021) & (USD Million)
Table 50. Asia-Pacific Longevity and Anti-senescence Therapy Revenue by Type (2021-2026) & (USD Million)
Table 51. Asia-Pacific Longevity and Anti-senescence Therapy Revenue by Application (2016-2021) & (USD Million)
Table 52. Asia-Pacific Longevity and Anti-senescence Therapy Revenue by Application (2021-2026) & (USD Million)
Table 53. Asia-Pacific Longevity and Anti-senescence Therapy Revenue by Region (2016-2021) & (USD Million)
Table 54. Asia-Pacific Longevity and Anti-senescence Therapy Revenue by Region (2021-2026) & (USD Million)
Table 55. South America Longevity and Anti-senescence Therapy Revenue by Type (2016-2021) & (USD Million)
Table 56. South America Longevity and Anti-senescence Therapy Revenue by Type (2021-2026) & (USD Million)
Table 57. South America Longevity and Anti-senescence Therapy Revenue by Application (2016-2021) & (USD Million)
Table 58. South America Longevity and Anti-senescence Therapy Revenue by Application (2021-2026) & (USD Million)
Table 59. South America Longevity and Anti-senescence Therapy Revenue by Country (2016-2021) & (USD Million)
Table 60. South America Longevity and Anti-senescence Therapy Revenue by Country (2021-2026) & (USD Million)
Table 61. Middle East & Africa Longevity and Anti-senescence Therapy Revenue by Type (2016-2021) & (USD Million)
Table 62. Middle East & Africa Longevity and Anti-senescence Therapy Revenue by Type (2021-2026) & (USD Million)
Table 63. Middle East & Africa Longevity and Anti-senescence Therapy Revenue by Application (2016-2021) & (USD Million)
Table 64. Middle East & Africa Longevity and Anti-senescence Therapy Revenue by Application (2021-2026) & (USD Million)
Table 65. Middle East & Africa Longevity and Anti-senescence Therapy Revenue by Country (2016-2021) & (USD Million)
Table 66. Middle East & Africa Longevity and Anti-senescence Therapy Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Longevity and Anti-senescence Therapy Picture
Figure 2. Global Longevity and Anti-senescence Therapy Revenue Market Share by Type in 2020
Figure 3. Hemolytic Drug Therapy
Figure 4. Gene Therapy
Figure 5. Immunotherapy
Figure 6. Other Stem Cell Therapies
Figure 7. Longevity and Anti-senescence Therapy Revenue Market Share by Application in 2020
Figure 8. Hospital Picture
Figure 9. Medical Service Institution Picture
Figure 10. Drug and Device Sales Picture
Figure 11. Global Longevity and Anti-senescence Therapy Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 12. Global Longevity and Anti-senescence Therapy Revenue and Forecast (2016-2026) & (USD Million)
Figure 13. Global Longevity and Anti-senescence Therapy Revenue Market Share by Region (2016-2026)
Figure 14. Global Longevity and Anti-senescence Therapy Revenue Market Share by Region in 2020
Figure 15. North America Longevity and Anti-senescence Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 16. Europe Longevity and Anti-senescence Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Asia-Pacific Longevity and Anti-senescence Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. South America Longevity and Anti-senescence Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Middle East and Africa Longevity and Anti-senescence Therapy Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Longevity and Anti-senescence Therapy Market Drivers
Figure 21. Longevity and Anti-senescence Therapy Market Restraints
Figure 22. Longevity and Anti-senescence Therapy Market Trends
Figure 23. CohBar Recent Developments and Future Plans
Figure 24. TA Sciences Recent Developments and Future Plans
Figure 25. Unity Biotechnology Recent Developments and Future Plans
Figure 26. AgeX Therapeutics，Inc Recent Developments and Future Plans
Figure 27. PowerVision Inc. Recent Developments and Future Plans
Figure 28. Global Longevity and Anti-senescence Therapy Revenue Share by Players in 2020
Figure 29. Longevity and Anti-senescence Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 30. Global Top 3 Players Longevity and Anti-senescence Therapy Revenue Market Share in 2020
Figure 31. Global Top 10 Players Longevity and Anti-senescence Therapy Revenue Market Share in 2020
Figure 32. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 33. Global Longevity and Anti-senescence Therapy Revenue Share by Type in 2020
Figure 34. Global Longevity and Anti-senescence Therapy Market Share Forecast by Type (2021-2026)
Figure 35. Global Longevity and Anti-senescence Therapy Revenue Share by Application in 2020
Figure 36. Global Longevity and Anti-senescence Therapy Market Share Forecast by Application (2021-2026)
Figure 37. North America Longevity and Anti-senescence Therapy Sales Market Share by Type (2016-2026)
Figure 38. North America Longevity and Anti-senescence Therapy Sales Market Share by Application (2016-2026)
Figure 39. North America Longevity and Anti-senescence Therapy Revenue Market Share by Country (2016-2026)
Figure 40. United States Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Longevity and Anti-senescence Therapy Sales Market Share by Type (2016-2026)
Figure 44. Europe Longevity and Anti-senescence Therapy Sales Market Share by Application (2016-2026)
Figure 45. Europe Longevity and Anti-senescence Therapy Revenue Market Share by Country (2016-2026)
Figure 46. Germany Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. France Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. United Kingdom Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Russia Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Italy Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Longevity and Anti-senescence Therapy Sales Market Share by Type (2016-2026)
Figure 52. Asia-Pacific Longevity and Anti-senescence Therapy Sales Market Share by Application (2016-2026)
Figure 53. Asia-Pacific Longevity and Anti-senescence Therapy Revenue Market Share by Region (2016-2026)
Figure 54. China Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Japan Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. South Korea Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. India Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Southeast Asia Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Australia Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. South America Longevity and Anti-senescence Therapy Sales Market Share by Type (2016-2026)
Figure 61. South America Longevity and Anti-senescence Therapy Sales Market Share by Application (2016-2026)
Figure 62. South America Longevity and Anti-senescence Therapy Revenue Market Share by Country (2016-2026)
Figure 63. Brazil Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Argentina Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Middle East and Africa Longevity and Anti-senescence Therapy Sales Market Share by Type (2016-2026)
Figure 66. Middle East and Africa Longevity and Anti-senescence Therapy Sales Market Share by Application (2016-2026)
Figure 67. Middle East and Africa Longevity and Anti-senescence Therapy Revenue Market Share by Country (2016-2026)
Figure 68. Turkey Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Saudi Arabia Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. UAE Longevity and Anti-senescence Therapy Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Methodology
Figure 72. Research Process and Data Source
長寿及び抗老化療法の世界市場 2019年版：種類別（溶血性薬物療法、遺伝子療法、免疫療法、その他の幹細胞療法）、用途別（病院、医療機関、医薬品＆デバイス販売） Scope of the Report: The global Longevity and Anti-senescence Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especial…- 世界の抗老化療法市場 2021：企業別、地域別、種類・用途別 The Anti-Senescence Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulat…
- 老化防止療法の世界市場 2019年版：種類別（遺伝子治療、免疫療法、その他）、用途別（心血管疾患、神経変性疾患、眼科疾患、その他） Scope of the Report: The global Anti-Senescence Therapy market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024. The Asia-Pacific will occupy for more market share in following years, especially in China, a…
- 世界の筋骨格系障害幹細胞治療市場 2021：企業別、地域別、種類・用途別 The Musculoskeletal Disorder Stem Cell Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 世界の中枢神経系疾患用遺伝子治療市場 2021：企業別、地域別、種類・用途別 The Gene Therapy for CNS Disorders market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade …